Table 2. In vitro susceptibility of Klebsiella pneumoniae to common antimicrobial agents.

ESBL-SCM: extended-spectrum β-lactamases-sulbactam

Antimicrobial agents	% Sensitive	% Resistant
Amikacin	44.7%	55.3%
Amoxicillin/ K Clavulanate	32.1%	67.9%
Ampicillin-sulbactam	20.8%	79.2%
Ampicillin	0.0%	100.0%
Aztreonam	20.9%	79.1%
Cefazolin	77.2%	22.8%
Cefepime	21.3%	78.7%
Cefitriaxone	17.9%	82.1%
Cefotaxime	31.1%	68.9%
Cefoxitin	37.2%	62.8%
Ceftazidime	32.7%	67.3%
Ceftazidime	7.5%	92.5%
Cefuroxime	27.5%	72.5%
Ciprofloxacin	35.8%	64.2%
Colistin	64.9%	35.1%
Ertapenem	34.8%	65.2%
ESBL- SCM	0.0%	100.0%
Gentamicin	42.9%	57.1%
Imipenem	55.5%	44.5%
Levofloxacin	36.8%	63.2%
Meropenem	38.3%	61.7%
Minocycline	19.8%	80.2%
Moxifloxacin	31.1%	68.9%
Nitrofurantoin	25.0%	75.0%
Norfloxacin	60.0%	40.0%
Piperacillin/ tazobactam	32.4%	67.6%
Piperacillin	0.0%	100.0%
Tetracycline	20.0%	80.0%
Ticarcillin/ K Clavulanate	50.0%	50.0%
Tigecycline	81.0%	19.0%
Tobramycin	29.7%	70.3%
Trimethoprim/ sulfamethoxazole	38.9%	61.1%